Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Duggan-Keen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Acta Neurologica Scandinavica|March 1, 1987
HLA (class 1 antigen) status and cell-mediated immunity in multiple sclerosisM Duggan-Keen, D F Roberts, J Wentzel
British Journal of Haematology|June 1, 1990
Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacsC R Hay, P McEvoy, M Duggan-Keen
Acta Neurologica Scandinavica|April 1, 1986
Cell-mediated immunological status in multiple sclerosis patientsM Duggan-Keen, D F Roberts, D Bates
Human Heredity|January 1, 1991
Factor B (BF) allotypes and multiple sclerosis in north-east EnglandS S Papiha, M Duggan-Keen, D F Roberts
Cancer Research|July 15, 1992
HLA class II antigen expression in human papillomavirus-associated cervical cancerS S Glew, M Duggan-Keen, T Cabrera, et al.
The British Journal of Ophthalmology|September 1, 1986
Immunogenetic studies in retinoblastomaD F Roberts, M Duggan-Keen, G E Aherne, et al.
Journal of Immunological Methods|November 23, 1987
ELISA measurement of IgG subclass production in culture supernatants using monoclonal antibodiesP Bird, J E Calvert, J Lowe, et al.
British Journal of Haematology|April 1, 1993
The peanut-agglutinin (PNA)-binding surface components of malignant plasma cellsJ R Slupsky, M Duggan-Keen, L A Booth, et al.
Immunology Today|February 1, 1997
Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursF Garrido, F Ruiz-Cabello, T Cabrera, et al.
Human Immunology|July 1, 1993
Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancerS S Glew, M Duggan-Keen, A K Ghosh, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Acta Neurologica Scandinavica|March 1, 1987
HLA (class 1 antigen) status and cell-mediated immunity in multiple sclerosisM Duggan-Keen, D F Roberts, J Wentzel
British Journal of Haematology|June 1, 1990
Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacsC R Hay, P McEvoy, M Duggan-Keen
Acta Neurologica Scandinavica|April 1, 1986
Cell-mediated immunological status in multiple sclerosis patientsM Duggan-Keen, D F Roberts, D Bates
Human Heredity|January 1, 1991
Factor B (BF) allotypes and multiple sclerosis in north-east EnglandS S Papiha, M Duggan-Keen, D F Roberts
Cancer Research|July 15, 1992
HLA class II antigen expression in human papillomavirus-associated cervical cancerS S Glew, M Duggan-Keen, T Cabrera, et al.
The British Journal of Ophthalmology|September 1, 1986
Immunogenetic studies in retinoblastomaD F Roberts, M Duggan-Keen, G E Aherne, et al.
Journal of Immunological Methods|November 23, 1987
ELISA measurement of IgG subclass production in culture supernatants using monoclonal antibodiesP Bird, J E Calvert, J Lowe, et al.
British Journal of Haematology|April 1, 1993
The peanut-agglutinin (PNA)-binding surface components of malignant plasma cellsJ R Slupsky, M Duggan-Keen, L A Booth, et al.
Immunology Today|February 1, 1997
Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursF Garrido, F Ruiz-Cabello, T Cabrera, et al.
Human Immunology|July 1, 1993
Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancerS S Glew, M Duggan-Keen, A K Ghosh, et al.
Pageof 2